News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Leukemia’ clear

  • Dana-Farber scientists report in the Journal of Clinical Investigation they have developed a tumor vaccine based on the patient’s tumor to create a strong and selective immune response in some chronic lymphocytic leukemia patients.

Tags: ImmuneSystem, Leukemia

  • The Leukemia & Lymphoma Society and Dana-Farber joined together to establish the Blood Cancer Research Partnership, an innovative program bringing together a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.

Tags: Leukemia, Lymphoma

  • Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."

Tags: BasicResearch, BreastCancer, Leukemia

  • Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.

Tags: Genetics, Leukemia

  • Dana-Farber Cancer Institute scientists provide the first statistically-based guidelines for determining whether stem cell transplant is appropriate for patients older than 60 with myelodysplastic syndromes (MDS)

Tags: StemCellTransplant, Leukemia

  • An analysis of two dozen clinical studies finds most adults with poor-risk and intermediate-risk acute myeloid leukemia benefit from allogeneic stem cell transplants.

Tags: BasicResearch, StemCellTransplant, Leukemia

  • Researchers report that patients with high-risk acute AML who received a cancer vaccine after a stem cell transplant had few complications and mounted a strong immune system attack on the disease.

Tags: StemCellTransplant, Leukemia

  • A new study charts the "genomic biography" of chronic lymphocytic leukemia, identifying gene mutations driving its growth, and tracing the shift in mutations as the disease progresses and develops resistance to chemotherapy, demonstrating the power of sequencing DNA in a large group of tumor tissue samples.

Tags: Genomics, Leukemia

  • The pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.

Tags: StemCellTransplant, Leukemia

  • Stand Up To Cancer announced the second round of awards for its Innovative Research Grants Program, naming the 13 young scientists who will receive a combined $9.74 million to conduct high-risk/high-reward translational cancer research. Dana-Farber's Catherine J. Wu, MD, is one of the recipients.

Tags: Grants, Honors, Prevention, Leukemia

Showing 1-10 of 31 items